Literature DB >> 9189740

Anti-insulin antibodies in insulin immunometric assays: a still possible pitfall.

R Sapin1.   

Abstract

Insulin was assayed directly using radioimmunoassay and immunometric assay in 31 sera containing anti-insulin antibodies. Anti-insulin antibodies were determined by radio-binding-assay. Insulin measurements were compared with those of free (unbound to antibodies, polyethylene glycol precipitated) insulin measurements. Compared with free insulin concentrations, radioimmunoassay and immunometric assay yielded falsely increased insulin results. The degree of overestimation by radioimmunoassay and by immunometric assay correlated with the anti-insulin antibody value. Anti-insulin antibodies still remain a possible pitfall in the insulin-specific immunometric assays which are now being widely used.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9189740     DOI: 10.1515/cclm.1997.35.5.365

Source DB:  PubMed          Journal:  Eur J Clin Chem Clin Biochem        ISSN: 0939-4974


  6 in total

1.  Interferences in immunoassay.

Authors:  Jill Tate; Greg Ward
Journal:  Clin Biochem Rev       Date:  2004-05

2.  The effects of anti-insulin antibodies and cross-reactivity with human recombinant insulin analogues in the E170 insulin immunometric assay.

Authors:  Serim Kim; Yeo Min Yun; Mina Hur; Hee Won Moon; Jin Q Kim
Journal:  Korean J Lab Med       Date:  2011-01

3.  The association between anti-insulin aspart antibodies and the pharmacokinetic and pharmacodynamic characteristics of fast-acting insulin aspart in children and adolescents with type 1 diabetes.

Authors:  Torben Biester; Thekla von dem Berge; Line Quist Bendtsen; Mette Dahl Bendtsen; Naveen Rathor; Thomas Danne; Hanne Haahr
Journal:  Pediatr Diabetes       Date:  2020-05-05       Impact factor: 4.866

4.  Clinical Pharmacology of Fast-Acting Insulin Aspart Versus Insulin Aspart Measured as Free or Total Insulin Aspart and the Relation to Anti-Insulin Aspart Antibody Levels in Subjects with Type 1 Diabetes Mellitus.

Authors:  Hanne Haahr; Thomas R Pieber; Chantal Mathieu; Theis Gondolf; Masanari Shiramoto; Lars Erichsen; Tim Heise
Journal:  Clin Pharmacokinet       Date:  2019-05       Impact factor: 6.447

5.  Multiplexed quantification of insulin and C-peptide by LC-MS/MS without the use of antibodies.

Authors:  North Foulon; Elisha Goonatilleke; Michael J MacCoss; Michelle A Emrick; Andrew N Hoofnagle
Journal:  J Mass Spectrom Adv Clin Lab       Date:  2022-06-10

Review 6.  Fast-Acting Insulin Aspart: A Review of its Pharmacokinetic and Pharmacodynamic Properties and the Clinical Consequences.

Authors:  Hanne Haahr; Tim Heise
Journal:  Clin Pharmacokinet       Date:  2020-02       Impact factor: 6.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.